• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
The 2011 World Forecasts of Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products Export Supplies - Product Image

The 2011 World Forecasts of Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products Export Supplies

  • ID: 1338982
  • June 2010
  • Region: Global
  • 109 pages
  • ICON Group International

This report was created for strategic planners, international marketing executives and export managers whose primary concern is the world market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products for those firms serving the world via exports and foreign direct investment. It does so for the current year based on a variety of key historical indicators and econometric models.

In what follows, this report begins by summarizing the world market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products exports. The total level of exports on a worldwide basis is based on a model that aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the READ MORE >

1 METHODOLOGY & EXECUTIVE SUMMARY
1.1 Our Approach
1.2 The World Market: Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products Export Supplies in 2011
1.3 The World Market: Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products by Destination in 2011
2 AFRICA: EXPORT SUPPLIES OF GLYCOSIDES, GLANDS OR OTHER ORGANS AND EXTRACTS, ANTISERA, VACCINES, AND SIMILAR PRODUCTS
2.1 Executive Summary
2.2 Botswana
2.3 Cameroon
2.4 Cote d'Ivoire
2.5 Egypt
2.6 Ethiopia
2.7 Guinea
2.8 Kenya
2.9 Mauritania
2.10 Morocco
2.11 South Africa
2.12 Swaziland
2.13 Tunisia
2.14 Zambia
2.15 Zimbabwe
3 ASIA: EXPORT SUPPLIES OF GLYCOSIDES, GLANDS OR OTHER ORGANS AND EXTRACTS, ANTISERA, VACCINES, AND SIMILAR PRODUCTS
3.1 Executive Summary
3.2 Brunei
3.3 China
3.4 Hong Kong
3.5 India
3.6 Indonesia
3.7 Japan
3.8 Malaysia
3.9 Nepal
3.10 North Korea
3.11 Philippines
3.12 Singapore
3.13 South Korea
3.14 Sri Lanka
3.15 Taiwan
3.16 Thailand
3.17 Vietnam
4 EUROPE: EXPORT SUPPLIES OF GLYCOSIDES, GLANDS OR OTHER ORGANS AND EXTRACTS, ANTISERA, VACCINES, AND SIMILAR PRODUCTS
4.1 Executive Summary
4.2 Austria
4.3 Belarus
4.4 Belgium
4.5 Bosnia and Herzegovina
4.6 Bulgaria
4.7 Croatia
4.8 Cyprus
4.9 Czech Republic
4.10 Denmark
4.11 Estonia
4.12 Finland
4.13 France
4.14 Georgia
4.15 Germany
4.16 Greece
4.17 Hungary
4.18 Iceland
4.19 Ireland
4.20 Italy
4.21 Kazakhstan
4.22 Latvia
4.23 Lithuania
4.24 Luxembourg
4.25 Macedonia
4.26 Malta
4.27 Norway
4.28 Poland
4.29 Portugal
4.30 Romania
4.31 Russia
4.32 Serbia and Montenegro
4.33 Slovakia
4.34 Slovenia
4.35 Spain
4.36 Sweden
4.37 Switzerland
4.38 the Netherlands
4.39 the United Kingdom
4.40 Ukraine
5 LATIN AMERICA: EXPORT SUPPLIES OF GLYCOSIDES, GLANDS OR OTHER ORGANS AND EXTRACTS, ANTISERA, VACCINES, AND SIMILAR PRODUCTS
5.1 Executive Summary
5.2 Argentina
5.3 Brazil
5.4 Chile
5.5 Colombia
5.6 Costa Rica
5.7 Ecuador
5.8 El Salvador
5.9 Guatemala
5.10 Honduras
5.11 Mexico
5.12 Nicaragua
5.13 Panama
5.14 Paraguay
5.15 Peru
5.16 Uruguay
5.17 Venezuela
6 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF GLYCOSIDES, GLANDS OR OTHER ORGANS AND EXTRACTS, ANTISERA, VACCINES, AND SIMILAR PRODUCTS
6.1 Executive Summary
6.2 Aruba
6.3 Barbados
6.4 Canada
6.5 Cuba
6.6 Dominican Republic
6.7 the Netherlands Antilles
6.8 the United States
7 OCEANA: EXPORT SUPPLIES OF GLYCOSIDES, GLANDS OR OTHER ORGANS AND EXTRACTS, ANTISERA, VACCINES, AND SIMILAR PRODUCTS
7.1 Executive Summary
7.2 Australia
7.3 Fiji
7.4 New Zealand
7.5 Vanuatu
8 THE MIDDLE EAST: EXPORT SUPPLIES OF GLYCOSIDES, GLANDS OR OTHER ORGANS AND EXTRACTS, ANTISERA, VACCINES, AND SIMILAR PRODUCTS
8.1 Executive Summary
8.2 Armenia
8.3 Iran
8.4 Israel
8.5 Jordan
8.6 Kuwait
8.7 Oman
8.8 Pakistan
8.9 Saudi Arabia
8.10 Syrian Arab Republic
8.11 the United Arab Emirates
8.12 Turkey
9 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
9.1 Disclaimers & Safe Harbor
9.2 ICON Group Ltd. User Agreement Provisions

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos